Revolutionary Oral Drug for Visceral Leishmaniasis Begins Phase II Trials in Ethiopia: A New Hope for Millions
Nairobi/Geneva, 24 April 2024 – A promising breakthrough in the fight against visceral leishmaniasis (VL), also known as kala-azar, has emerged as an innovative oral drug enters Phase II clinical trials in Ethiopia. […]
AFRICA FEATURED General Health Human Rights Investigative Reports Latest Magazine News Radio & TV Special Edition TOP STORIES TOP VIDEOS